CFSAN Priorities: Industry & Consumer Groups Weigh In On NDIs And More

FDA should accept safety findings from outside expert panels when reviewing new dietary ingredient notifications, CHPA says in Aug. 25 comments on CFSAN priorities

More from Archive

More from Pink Sheet